Trials / Completed
CompletedNCT00930488
Treatment of Patients With Acute Sinusitis
Treatment of Patients With Acute Sinusitis in Daily Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 6,777 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
For each patient, an initial visit and at least one follow-up visit at the end of treatment should be documented by the treating physician in the case report form.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Avelox (Moxifloxacin, BAY12-8039) | Patients with a diagnosis of acute bacterial sinusitis who take moxifloxacin |
Timeline
- Start date
- 2007-03-01
- Primary completion
- 2008-12-01
- Completion
- 2008-12-01
- First posted
- 2009-06-30
- Last updated
- 2012-11-20
Locations
19 sites across 19 countries: Austria, Bahrain, China, Egypt, France, Germany, Indonesia, Jordan, Kuwait, Lebanon, Malaysia, Netherlands, Pakistan, Philippines, Romania, Saudi Arabia, Singapore, United Arab Emirates, Yemen
Source: ClinicalTrials.gov record NCT00930488. Inclusion in this directory is not an endorsement.